_id
69171d073c536f8df23166d0
Ticker
TELO
Name
Telomir Pharmaceuticals, Inc. Common Stock
Exchange
NASDAQ
Address
100 SE 2nd Street, Miami, FL, United States, 33131
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://telomirpharma.com
Description
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Last Close
1.47
Volume
128091
Current Price
1.39
Change
-0.04
Last Updated
2026-01-07T12:58:05.402Z
Image
data:image/webp;base64,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
Ipo Date
2024-02-09T00:00:00.000Z
Market Cap
49852412
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
-
Target Price
15.5
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1146476
Operating Income
-1146476
Interest Expense
2730
Pretax Income
-1102294
Net Income
-1102294
Eps
-0.03551209015577467
Dividends Per Share
-
Shares Outstanding
34380971
Income Tax Expense
-
EBITDA
-1099564
Operating Margin
-
Total Other Income Expense Net
44182
Cash
7329298
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
7402117
Property Plant Equipment
-
Total Assets
7402117
Payables
329375
Short Term Debt
-
Long Term Debt
-
Total Liabilities
422807
Equity
6979310
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
76887
Cash From Operations
-927265
Capital Expenditures
5
Cash From Investing
-
Cash From Financing
7502239
Net Change In Cash
6574975
Cf_currency_symbol
USD
PE
-
PB
6.181921989423023
ROE
-15.79373892261556
ROA
-14.891604658505129
FCF
-927270
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1146476
Quarters > 0 > income Statement > operating Income
-1146476
Quarters > 0 > income Statement > interest Expense
2730
Quarters > 0 > income Statement > pretax Income
-1102294
Quarters > 0 > income Statement > net Income
-1102294
Quarters > 0 > income Statement > eps
-0.03551209015577467
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
31039964
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1099564
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
44182
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7329298
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7402117
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
7402117
Quarters > 0 > balance Sheet > payables
329375
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
422807
Quarters > 0 > balance Sheet > equity
6979310
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1102294
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
76887
Quarters > 0 > cash Flow > cash From Operations
-927265
Quarters > 0 > cash Flow > capital Expenditures
5
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
7502239
Quarters > 0 > cash Flow > net Change In Cash
6574975
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.03551209015577467
Quarters > 0 > ratios > PB
6.181921989423023
Quarters > 0 > ratios > ROE
-15.79373892261556
Quarters > 0 > ratios > ROA
-14.891604658505129
Quarters > 0 > ratios > FCF
-927270
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
5069910
Quarters > 1 > income Statement > operating Income
-5069910
Quarters > 1 > income Statement > interest Expense
1342
Quarters > 1 > income Statement > pretax Income
-5069890
Quarters > 1 > income Statement > net Income
-5069890
Quarters > 1 > income Statement > eps
-0.16893909113795275
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
30010165
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5068548
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
20
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
754323
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
829611
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
829611
Quarters > 1 > balance Sheet > payables
254956
Quarters > 1 > balance Sheet > short Term Debt
93432
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
348388
Quarters > 1 > balance Sheet > equity
481223
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5069890
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-291004
Quarters > 1 > cash Flow > cash From Operations
-696444
Quarters > 1 > cash Flow > capital Expenditures
4
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1047769
Quarters > 1 > cash Flow > net Change In Cash
351324
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.16893909113795275
Quarters > 1 > ratios > PB
86.68357362387083
Quarters > 1 > ratios > ROE
-1053.5427442162988
Quarters > 1 > ratios > ROA
-611.116535340057
Quarters > 1 > ratios > FCF
-696448
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2187782
Quarters > 2 > income Statement > operating Income
-2187782
Quarters > 2 > income Statement > interest Expense
7954
Quarters > 2 > income Statement > pretax Income
-2179828
Quarters > 2 > income Statement > net Income
-2179828
Quarters > 2 > income Statement > eps
-0.07324033518362649
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29762671
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2179828
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
7954
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
402999
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
491188
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
491188
Quarters > 2 > balance Sheet > payables
558862
Quarters > 2 > balance Sheet > short Term Debt
93432
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
652294
Quarters > 2 > balance Sheet > equity
-161106
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2179828
Quarters > 2 > cash Flow > depreciation
2187782
Quarters > 2 > cash Flow > change In Working Capital
-30315
Quarters > 2 > cash Flow > cash From Operations
-863132
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-863132
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.07324033518362649
Quarters > 2 > ratios > PB
-256.7881561828858
Quarters > 2 > ratios > ROE
1353.0396136705028
Quarters > 2 > ratios > ROA
-443.7869003314413
Quarters > 2 > ratios > FCF
-863132
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
18793476
Quarters > 3 > income Statement > cost Of Revenue
9396738
Quarters > 3 > income Statement > gross Profit
9396738
Quarters > 3 > income Statement > operating Expenses
2905435
Quarters > 3 > income Statement > operating Income
-2905435
Quarters > 3 > income Statement > interest Expense
1
Quarters > 3 > income Statement > pretax Income
-2898373
Quarters > 3 > income Statement > net Income
-2898373
Quarters > 3 > income Statement > eps
-0.09811948650368854
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
29539219
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2898374
Quarters > 3 > income Statement > operating Margin
-15.459806371104525
Quarters > 3 > income Statement > total Other Income Expense Net
7062
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1266131
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1324005
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1324005
Quarters > 3 > balance Sheet > payables
587536
Quarters > 3 > balance Sheet > short Term Debt
93432
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
680968
Quarters > 3 > balance Sheet > equity
643037
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2898373
Quarters > 3 > cash Flow > depreciation
-1957000
Quarters > 3 > cash Flow > change In Working Capital
100529
Quarters > 3 > cash Flow > cash From Operations
-605808
Quarters > 3 > cash Flow > capital Expenditures
2
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1037301
Quarters > 3 > cash Flow > net Change In Cash
431493
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.09811948650368854
Quarters > 3 > ratios > PB
63.85249124078396
Quarters > 3 > ratios > ROE
-450.7319174479851
Quarters > 3 > ratios > ROA
-218.9095207344383
Quarters > 3 > ratios > FCF
-605810
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.03223512244355435
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-09-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
12242174
Annuals > 0 > income Statement > operating Income
-12242174
Annuals > 0 > income Statement > interest Expense
4338542
Annuals > 0 > income Statement > pretax Income
-16532716
Annuals > 0 > income Statement > net Income
-16532716
Annuals > 0 > income Statement > eps
-0.5596869707354145
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
29539219
Annuals > 0 > income Statement > income Tax Expense
-16532716
Annuals > 0 > income Statement > EBITDA
48000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-4290542
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1266131
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1324005
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
1324005
Annuals > 0 > balance Sheet > payables
587536
Annuals > 0 > balance Sheet > short Term Debt
93432
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
680968
Annuals > 0 > balance Sheet > equity
643037
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-16532716
Annuals > 0 > cash Flow > depreciation
4338543
Annuals > 0 > cash Flow > change In Working Capital
126469
Annuals > 0 > cash Flow > cash From Operations
-5070428
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
6335328
Annuals > 0 > cash Flow > net Change In Cash
1264900
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.5596869707354145
Annuals > 0 > ratios > PB
66.60871388427104
Annuals > 0 > ratios > ROE
-2571.0365033427315
Annuals > 0 > ratios > ROA
-1248.6898463374382
Annuals > 0 > ratios > FCF
-5070428
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
17
Annuals > 1 > quarter
2023-09-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3942048
Annuals > 1 > income Statement > gross Profit
-3942048
Annuals > 1 > income Statement > operating Expenses
3942048
Annuals > 1 > income Statement > operating Income
-3942048
Annuals > 1 > income Statement > interest Expense
1643049
Annuals > 1 > income Statement > pretax Income
-13071864
Annuals > 1 > income Statement > net Income
-13071864
Annuals > 1 > income Statement > eps
-0.4414706556414032
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29609814
Annuals > 1 > income Statement > income Tax Expense
-2298999
Annuals > 1 > income Statement > EBITDA
-11428815
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-9129816
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1231
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
130000
Annuals > 1 > balance Sheet > inventories
303281
Annuals > 1 > balance Sheet > total Current Assets
435225
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
4773768
Annuals > 1 > balance Sheet > payables
707187
Annuals > 1 > balance Sheet > short Term Debt
101000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1335564
Annuals > 1 > balance Sheet > equity
3438204
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-13071864
Annuals > 1 > cash Flow > depreciation
1611458
Annuals > 1 > cash Flow > change In Working Capital
113843
Annuals > 1 > cash Flow > cash From Operations
-3859796
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
3859608
Annuals > 1 > cash Flow > net Change In Cash
-188
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.4414706556414032
Annuals > 1 > ratios > PB
12.487400485835046
Annuals > 1 > ratios > ROE
-380.1945434302328
Annuals > 1 > ratios > ROA
-273.82696436022866
Annuals > 1 > ratios > FCF
-3859800
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-09-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
854147
Annuals > 2 > income Statement > operating Income
-854147
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-854147
Annuals > 2 > income Statement > net Income
-854147
Annuals > 2 > income Statement > eps
-0.028846753309561487
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
29609814
Annuals > 2 > income Statement > income Tax Expense
-854144
Annuals > 2 > income Statement > EBITDA
-854147
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
3
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1419
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
48730
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
48730
Annuals > 2 > balance Sheet > payables
404221
Annuals > 2 > balance Sheet > short Term Debt
581787
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
986008
Annuals > 2 > balance Sheet > equity
-937278
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-854147
Annuals > 2 > cash Flow > depreciation
854147
Annuals > 2 > cash Flow > change In Working Capital
385486
Annuals > 2 > cash Flow > cash From Operations
-468661
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
470080
Annuals > 2 > cash Flow > net Change In Cash
1419
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.028846753309561487
Annuals > 2 > ratios > PB
-45.80735950273025
Annuals > 2 > ratios > ROE
91.13059305776942
Annuals > 2 > ratios > ROA
-1752.815514057049
Annuals > 2 > ratios > FCF
-468661
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-09-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
138131
Annuals > 3 > income Statement > operating Income
-138131
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-138131
Annuals > 3 > income Statement > net Income
-138131
Annuals > 3 > income Statement > eps
-0.004665041124540668
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
29609814
Annuals > 3 > income Statement > income Tax Expense
-138132
Annuals > 3 > income Statement > EBITDA
-138131
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
0
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
0
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
55000
Annuals > 3 > balance Sheet > payables
18735
Annuals > 3 > balance Sheet > short Term Debt
119396
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
138131
Annuals > 3 > balance Sheet > equity
-83131
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-138131
Annuals > 3 > cash Flow > depreciation
138131
Annuals > 3 > cash Flow > change In Working Capital
18735
Annuals > 3 > cash Flow > cash From Operations
-119396
Annuals > 3 > cash Flow > capital Expenditures
4
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
119396
Annuals > 3 > cash Flow > net Change In Cash
0
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.004665041124540668
Annuals > 3 > ratios > PB
-516.4647399886925
Annuals > 3 > ratios > ROE
166.16063802913473
Annuals > 3 > ratios > ROA
-251.14727272727274
Annuals > 3 > ratios > FCF
-119400
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.03551209015577467
Valuation > metrics > PB
6.181921989423023
Valuation > final Score
20
Valuation > verdict
106.1% Overvalued
Profitability > metrics > ROE
-15.79373892261556
Profitability > metrics > ROA
-14.891604658505129
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.06058005734091192
Risk > metrics > Interest Coverage
-419.95457875457873
Risk > final Score
-1620
Risk > verdict
High
Liquidity > metrics > Current Ratio
22.473220493358635
Liquidity > metrics > Quick Ratio
22.473220493358635
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
55
Prev Profitabilities > 2
0
Prev Risks > 0
-15064
Prev Risks > 1
-1070
Prev Risks > 2
-11621710
Prev Liquidities > 0
100
Prev Liquidities > 1
48
Prev Liquidities > 2
99
Updated At
2026-01-20T22:40:55.196Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-12
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-02
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-11-10
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.03
Earnings History > 2 > eps Estimate
-0.07
Earnings History > 2 > eps Difference
0.04
Earnings History > 2 > surprise Percent
57.1429
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-14
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.08
Earnings History > 3 > eps Difference
-0.09
Earnings History > 3 > surprise Percent
-112.5
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-14
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.07
Earnings History > 4 > eps Estimate
-0.1
Earnings History > 4 > eps Difference
0.03
Earnings History > 4 > surprise Percent
30
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-04
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.1
Earnings History > 5 > eps Estimate
-0.05
Earnings History > 5 > eps Difference
-0.05
Earnings History > 5 > surprise Percent
-100
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-11-11
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2023
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-08-13
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0489
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-03-31
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.2252
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATelo Genomics Seeks Up to $1.2 Million via Convertible Debenture Financing TipRanks
Read more →Financial Survey: Telomir Pharmaceuticals (NASDAQ:TELO) versus electroCore (NASDAQ:ECOR) Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Telomir Pharmaceuticals, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.03
EPS Estimate
-0.07
EPS Difference
0.04
Surprise Percent
57.1429%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.